Results 81 to 90 of about 1,067 (90)

HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects

Journal of Lipid Research, 2007
Kelley M Argraves, W Scott Argraves
exaly  

Evaluation of Lysosphingolipid Analysis for the Diagnosis of Lysosomal Storage Disease

Klinische Padiatrie
Murat Öktem, Berrak Bilginer Gurbuz, Leyla Tümer   +2 more
exaly  

Activation of Phosphatidylinositol-Specific Phospholipase C by HDL-Associated Lysosphingolipid. Involvement in Mitogenesis but Not in Cholesterol Efflux

Biochemistry, 2000
Jerzy-Roch Nöfer, Manfred Fobker, Reinhard Voß   +2 more
exaly  

Sphingosine-1-phosphate rapidly induces Rho-dependent neurite retraction: action through a specific cell surface receptor.

EMBO Journal, 1996
F R Postma, Kees Jalink, T Hengeveld
exaly  

FTY720, a Synthetic Sphingosine 1 Phosphate Analogue, Inhibits Development of Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice

Circulation, 2007
Jerzy-Roch Nöfer, Gerd Assmann, Erik A L Biessen   +2 more
exaly  

Psychosine blocks quisqualate-induced glutamate excitotoxicity in hippocampal CA sector neurons

Brain Research, 1998
Deborah M Hodgson
exaly  

Lysosphingolipid Quantitation in Plasma and Dried‐Blood Spots Using Targeted High‐Resolution Mass Spectrometry

Journal of Clinical Laboratory Analysis
Carine Pilon, Juliette Berger, Esther Noel   +2 more
exaly  

Simultaneous inhibition of mTOR and STING as an approach to reduce alpha-synuclein and lysosphingolipid levels in peripheral blood monocytederived macrophages and the SH-SY5Y cell line: implications for therapy of Parkinson’s disease

Biomeditsinskaya Khimiya
Tatiana Usenko
exaly  

Comparison of noradrenaline and lysosphingolipid-induced vasoconstriction in mouse and rat small mesenteric arteries

Autonomic and Autacoid Pharmacology, 2004
exaly  

Development and Validation of a Multiplex LC-MS/MS Assay for Lysosphingolipid Quantification in the Diagnosis of Gaucher and Fabry Diseases

exaly